Skip to main content
SpringerLink
Log in

The Role of Molecular Markers to Monitor Breakdown and Repair

  • Chapter
Osteoarthritis

  • 301 Accesses

Abstract

The functional deterioration and failure of joint cartilage in osteoarthritis results from changes in its cells and matrix. Significant changes occur in both synthesis, degradation and structure of matrix molecules of cartilage and other joint tissues during the different phases of development of OA.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Vincenti MP, Clark IM, Brinckerhoff CE (1994) Using inhibitors of metalloproteinases to treat arthritis. Easier said than done? Arthritis Rheum 37: 1115–1126

    Article  PubMed  CAS  Google Scholar 

  2. Consensus document (1998) The Bone and Joint Decade 2000–2010 for prevention and treatment of musculo-skeletal disorders. Acta Orthop Scand 69: 67–86

    Google Scholar 

  3. Lequèsne MG, Mery C, Samson M, Gerard P (1987) Indexes of severity for osteoarthritis of the hip and knee. Validation-Value in comparison with other assessment tests. Scand J Rheumatol [Suppl] 65: 85–89

    Article  Google Scholar 

  4. Bellamy N, Buchanan WW, Goldsmith CH, Campbell J, Stitt LW (1988) Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee. J Rheumatol 15: 1833–1840

    PubMed  CAS  Google Scholar 

  5. Rivest C, Liang M (1998). Evaluating outcome in osteoarthritis for research and clinical practise. In: Brandt KD, Doherty M, Lohmander LS (eds) Osteoarthritis. Oxford University Press, Oxford, pp 403–414

    Google Scholar 

  6. Hodgson RJ, Barry MA, Carpenter TA, Hall L, Hazleman B L, Tyler JA (1995) Magnetic resonance imaging protocol optimization for evaluation of hyaline cartilage in the distal interphalangeal joint of fingers. Invest Radiol 30: 522–531

    Article  PubMed  CAS  Google Scholar 

  7. Buckland-Wright JC (1998) Quantitation of radiographic changes. In: Brandt KD, Doherty M, Lohmander LS (eds) Osteoarthritis. Oxford University Press, Oxford, pp 459–472

    Google Scholar 

  8. Peterfy CG (1998) Magnetic resonance imaging. In: Brandt KD, Doherty M, Lohmander LS (eds) Osteoarthritis. Oxford University Press, Oxford, pp 473–494

    Google Scholar 

  9. Ayral X, Altman RD (1998) Arthroscopic evaluation of knee articular cartilage. In: Brandt KD, Doherty M, Lohmander LS (eds) Osteoarthritis. Oxford University Press, Oxford, PP 494–505

    Google Scholar 

  10. Myers S (1998) Ultrasonography. In: Brandt KD, Doherty M, Lohmander LS (eds) Osteoarthritis. Oxford University Press, Oxford pp 512–518

    Google Scholar 

  11. Schauwecker DS (1998) Bone scintigraphy. In: Brandt KD, Doherty M, Lohmander LS (eds) Osteoarthritis. Oxford University Press, Oxford, p 506–511

    Google Scholar 

  12. Lohmander LS (1994) Articular Cartilage and Osteoarthrosis-The role of molecular markers to monitor breakdown, repair and disease. J Anat 184: 477–492

    PubMed  CAS  Google Scholar 

  13. Lohmander LS, Felson DT (1998) Defining and validating the clinical role of molecular markers in osteoarthritis. In: Brandt KD, Doherty M, Lohmander LS (eds) Osteoarthritis. Oxford University Press, Oxford, pp 519–530

    Google Scholar 

  14. Dieppe P, Altman R, Buckwalter J, Felson D, Hascall V, Kuettner K, Lohmander LS, Peterfy C, Roos H (1995) Standardisation of methods used to assess the progression of osteoarthritis of hip and knee. In: Kuettner K, Goldberg V (eds) Osteoarthritic Disorders. American Academy of Orthopedic Surgeons, Rosemont, pp 481–496

    Google Scholar 

  15. Altman R, Brandt K, Hochberg M, Moskowitz R, Bellamy N, Bloch DA, Buckwalter J, Dougados M, Ehrlich M, Lequèsne M, Lohmander LS, Murphy WA, Rosario-Jansen T, Schwartz B, Trippel S (1996) Design and conduct of clinical trials in patients with osteoarthritis: Recommendations from a task force of the Osteoarthritis Research Society. Osteoarthritis Cartilage 4: 217–243

    Article  PubMed  CAS  Google Scholar 

  16. Bellamy N (1998) Design of clinical trials for evaluation of disease-modifying osteoarthritis drugs (DMOADS) and of new agents for symptomatic treatment of osteoarthritis. In: Brandt KD, Doherty M, Lohmander LS (eds) Osteoarthritis. Oxford University Press, Oxford, pp 531–542

    Google Scholar 

  17. Lohmander LS (1991) Markers of cartilage metabolism in arthrosis. A review. Acta Orthop Scand 62: 623–632

    Article  PubMed  CAS  Google Scholar 

  18. Poole AR (1994) Immunochemical markers of joint inflammation, skeletal damage and repair; where are we now? Ann Rheum Dis 53: 3–5

    Article  PubMed  CAS  Google Scholar 

  19. Saxne T, Heinegård D (1995) Matrix proteins: potentials as body fluid markers of changes in the metabolism of cartilage and bone in arthritis. J Rheumatol 22 [Suppl 43]: 71–74

    Google Scholar 

  20. Lohmander LS, Saxne T, Heinegård D (eds) (1995) Molecular markers of joint and skeletal diseases. Acta Orthop Scand 66 [Suppl 266]: 1–212

    Google Scholar 

  21. Wallis WJ, Simkin PA, Nelp WB (1987) Protein traffic in human synovial effusions. Arthritis Rheum 30: 57–63

    Article  PubMed  CAS  Google Scholar 

  22. Levick JR (1992) Synovial fluid. Determinants of volume turnover and material concentration. In: Kuettner KE, Schleyerbach R, Peyron JG, Hascall VC (eds) Articular cartilage and osteoarthritis. Raven, New York, pp 529–541

    Google Scholar 

  23. Simkin PA, Bassett JE (1995) Cartilage matrix molecules in serum and synovial fluid. Current Opin Rheumatol 7: 346–351

    Article  CAS  Google Scholar 

  24. Dahlberg L, Ryd L, Heinegård D, Lohmander LS (1992) Proteoglycan fragments in joint fluid-influence of arthrosis and inflammation. Acta Orthop Scand 63: 417–423

    Article  PubMed  CAS  Google Scholar 

  25. Myers SL, O’Connor BL, Brandt KD (1996) Accelerated clearance of albumin from the osteoarthritic knee: implications for interpretation of concentrations of “cartilage markers” in synovial fluid. J Rheumatol 23: 1744–1748

    PubMed  CAS  Google Scholar 

  26. Lohmander LS, Hoerrner LA, Lark MW (1993a) Metalloproteinases, tissue inhibitor and proteoglycan fragments in knee synovial fluid in human osteoarthritis. Arthritis Rheum 36: 181–189

    PubMed  CAS  Google Scholar 

  27. Lohmander LS, Saxne T, Heinegård D (1994) Release of cartilage oligomeric matrix protein (COMP) into joint fluid after injury and in osteoarthrosis. Ann Rheum Dis 53: 8–13

    Article  PubMed  CAS  Google Scholar 

  28. Lohmander LS, Yoshihara Y, Roos H, Kobayashi T, Yamada H, Shinmei M (1996a) Procollagen II C-propeptide in joint fluid. Changes in concentrations with age, time after joint injury and osteoarthritis. J Rheumatol 23: 1765–1769

    PubMed  CAS  Google Scholar 

  29. Lohmander LS, Ionescu M, Jugessur H, Poole AR (1998a) Changes in joint cartilage aggrecan metabolism after knee injury and in osteoarthritis. Arthritis Rheum, in press

    Google Scholar 

  30. Eyre DR, McDevitt CA, Billingham ME, Muir H (1980) Biosynthesis of collagen and other matrix proteins by articular cartilage in experimental osteoarthritis. Biochem J 188: 823–837

    PubMed  CAS  Google Scholar 

  31. Carney SL, Billingham MEJ, Muir H, Sandy JD (1984) Demonstration of increased proteoglycan turnover in cartilage expiants from dogs with experimental osteoarthritis. J Orthop Res 2: 201–206

    Article  PubMed  CAS  Google Scholar 

  32. Aigner T, Stöss H, Weseloh G, Zeiler G, von der Mark K (1992) Activation of collagen type II expression in osteoarthritic and rheumatoid cartilage. Virchows Archiv B Cell Pathol 62: 337–345

    Article  CAS  Google Scholar 

  33. Heinegård D, Bayliss M, Lorenzo P (1998) Biochemistry and metabolism of normal and osteoarthritic cartilage. In: Brandt KD, Doherty M, Lohmander LS (eds) Osteoarthritis. Oxford University Press, Oxford, pp 74–84

    Google Scholar 

  34. Mok SS, Masuda K, Häuselmann HJ, Aydelotte MB, Thonar EJ-MA (1994) Aggrecan synthesized by mature bovine chondrocytes suspended in alginate. Identification of two distinct metabolic matrix pools. J Biol Chem 269: 33021–33027

    PubMed  CAS  Google Scholar 

  35. Poole AR, Ionescu M, Swan A, Dieppe PA (1994) Changes in cartilage metabolism in arthritis are reflected by altered serum and synovial fluid levels of the cartilage proteoglycan aggrecan-implications for pathogenesis. J Clin Invest 94: 25–33

    Article  PubMed  CAS  Google Scholar 

  36. Visco DM, Johnstone B, Hill MA, Jolly GA, Caterson B (1993) Immunohistochemical analysis of 3-B-3(-) and 7-D-4 epitope expression in canine osteoarthritis. Arthritis Rheum 36: 1718–1725

    Article  PubMed  CAS  Google Scholar 

  37. Plaas AHK, WongPalms S, Roughley PJ, Midura RJ, Hascall VC (1997) Chemical and immunological assay of the nonreducing terminal residues of chondroitin sulfate from human aggrecan. J Biol Chem 272: 20603–20610

    Article  PubMed  CAS  Google Scholar 

  38. Plaas AHK, West LA, Wong-Palms S, Nelson F (1998) Glycosaminoglycan sulfation in human osteoarthrtitis. Disease-related alterations at the non-reducing termini of chondroitin and dermatan sulfate. J Biol Chem 273: 12642–12649

    Article  PubMed  CAS  Google Scholar 

  39. Hauser N, Geiss J, Neidhart M, Paulsson M, Häuselmann HJ (1995) Distribution of CMP and COMP in human cartilage. Acta Orthop Scand 66 [Suppl 266]: 72–73

    Google Scholar 

  40. Wolfe GC, MacNaul KL, Buechel FF, McDonnell J, Hoerrner LA, Lark MW, Moore VL, Hutchinson NI (1993) Differential in vivo expression of collagenase messenger RNA in synovium and cartilage. Quantitative comparison with stromelysin messenger RNA levels in human rheumatoid arthritis and osteoarthritis patients and in two animal models of acute inflammatory arthritis. Arthritis Rheum 36: 1540–1547

    Article  PubMed  CAS  Google Scholar 

  41. Roos H, Dahlberg L, Hoerrner LA, Lark MW, Thonar EJ-MA, Shinmei M, Lindquist U, Lohmander LS (1995) Markers of cartilage matrix metabolism in human joint fluid and serum-The effect of exercise. Osteoarthritis Cartilage 3: 7–14

    Article  PubMed  CAS  Google Scholar 

  42. Laurent TC, Fraser RE (1992) Hyaluronan. FASEB Journal 6: 2397–2404

    PubMed  CAS  Google Scholar 

  43. Thonar EJ-MA, Lenz ME, Klintworth GK, Caterson B, Pachman LM, Glickman P, Katz R, Huff J, Kuettner KE (1985) Quantification of keratan sulfate in blood as a marker of cartilage catabolism. Arthritis Rheum 28: 1367–1376

    Article  PubMed  CAS  Google Scholar 

  44. Spector TD, Woodward L, Hall GM, Hammond A, Williams A, Butler MG, James IT, Hart DJ, Thompson PW, Scott DL (1992) Keratan sulphate in rheumatoid arthritis, osteoarthritis, and inflammatory diseases. Ann Rheum Dis 51: 1134–1137

    Article  PubMed  CAS  Google Scholar 

  45. Thonar EJ-MA, Shinmei M, Lohmander LS (1993) Body Fluid Markers of Cartilage Changes in Osteoarthritis. Rheum Dis Clin North America 19: 635–657

    CAS  Google Scholar 

  46. Lohmander LS, Thonar EJ-MA (1994) Serum keratan sulfate concentrations are different in primary and posttraumatic osteoarthrosis of the knee (abstract). Trans Orthop Res Soc 19: 459

    Google Scholar 

  47. Petersson IF, Sandquist L, Svensson B, Saxne T (1997) Cartilage markers in synovial fluid in symptomatic knee osteoarthritis. Ann Rheum Dis 56: 64–67

    Article  PubMed  CAS  Google Scholar 

  48. Saxne T, Heinegård D, Wollheim FA (1987) Cartilage proteoglycans in synovial fluid and serum in patients with inflammatory joint disease. Arthritis Rheum 30: 972–979

    Article  PubMed  CAS  Google Scholar 

  49. Belcher C, Yaqub R, Fawthrop F, Bayliss M, Doherty M (1997) Synovial fluid chondroitin and keratan sulphate epitopes, glycosaminoglycans, and hyaluronan in arthritic and normal knees. Ann Rheum Dis 56: 299–307

    Article  PubMed  CAS  Google Scholar 

  50. Saxne T, Heinegård D (1992 a) Synovial fluid analysis of two groups of proteoglycan epitopes distinguishes early and late cartilage lesions. Arthritis Rheum 35: 385–390

    Article  PubMed  CAS  Google Scholar 

  51. Sharif M, George E, Shepstone L, Knudson W, Thonar EJ, Cushnagan J, Dieppe P (1995a) Serum hyaluronic acid level as a predictor of disease progression in osteoarthritis of the knee. Arthritis Rheum 38: 760–767

    Article  PubMed  CAS  Google Scholar 

  52. Sharif M, Saxne T, Shepstone L, Kirwan JR, Elson CR, Heinegård D, Dieppe PA (1995b) Relationship between serum cartilage oligomeric matrix protein levels and disease progression in osteoarthritis of the knee joint. Br J Rheumatol 34: 306–310

    Article  PubMed  CAS  Google Scholar 

  53. Månsson B, Carey D, Alini M, Ionescu M, Rosenberg LC, Poole AR, Heinegård D, Saxne T (1995) Cartilage and bone metabolism in rheumatoid arthritis. Differences between rapid and slow progression of disease identified by serum markers of cartilage metabolism. J Clin Invest 95: 1071–1077

    Article  PubMed  Google Scholar 

  54. Spector TD, Hart DJ, Nandra D, Doyle DV, Mackillop N, Gallimore JR, Pepys MB (1997) Low-level increases in serum C-reactive protein are present in early osteoarthritis of the knee and predict progressive disease. Arthritis Rheum 40: 723–727

    Article  PubMed  CAS  Google Scholar 

  55. Clark IM, Powell LK, Ramsey S, Hazleman BL, Cawston TE (1993) The measurement of collagenase, tissue inhibitor of metalloproteinases (TIMP), and collagenase-TIMP complex in synovial fluids from patients with osteoarthritis and rheumatoid arthritis. Arthritis Rheum 36: 372–379

    Article  PubMed  CAS  Google Scholar 

  56. Manicourt DH, Fujimoto N, Obata K, Thonar EJ (1994) Serum levels of collagenase, stromelysin-1, and TIMP-1. Age-and sex-related differences in normal subjects and relationship to the extent of joint involvement and serum levels of antigenic keratan sulfate in patients with osteoarthritis. Arthritis Rheum 37: 1774–1783

    Article  PubMed  CAS  Google Scholar 

  57. Zucker S, Lysik RM, Zarrabi MH, Greenwald RA, Gruber B, Tickle SP, Baker T, Docherty AJP (1994) Elevated plasma stromelysin levels in arthritis. J Rheumatol 21: 2329–2333

    PubMed  CAS  Google Scholar 

  58. Yoshihara Y, Obata KI, Fujimoto N, Yamashita K, Hayakawa T, Shimmei M (1995) Increased levels of stromelysin-1 and tissue inhibitor of metalloproteinases-1 in sera from patients with rheumatoid arthritis. Arthritis Rheum 38: 969–975

    Article  PubMed  CAS  Google Scholar 

  59. Sandy JD, Flannery CR, Neame PJ, Lohmander LS (1992) The structure of aggrecan fragments in human synovial fluid: Evidence for the involvement in osteoarthritis of a novel proteinase which cleaves the glu 373-ala 374 bond of the interglobular domain. J Clin Invest 89: 1512–1516

    Article  PubMed  CAS  Google Scholar 

  60. Lohmander LS, Neame P, Sandy JD (1993b) The structure of aggrecan fragments in human synovial fluid: Evidence that aggrecanase mediates cartilage degradation in inflammatory joint disease, joint injury and osteoarthritis. Arthritis Rheum 36: 1214–1222

    Article  PubMed  CAS  Google Scholar 

  61. Lark MW, Bayne EK, Flanagan J, Harper CF, Hoerrner LA, Hutchinson NI, Singer II, Donatelli SA, Weidner JR, Williams HR, Mumford RA, Lohmander LS (1997) Aggrecan degradation in human cartilage. Evidence for both aggrecanase and matrix metalloproteinase activity in normal, osteoarthritic and rheumatoid joints. J Clin Invest 100: 93–106

    Article  PubMed  CAS  Google Scholar 

  62. Saxne T, Heinegård D, Wollheim FA (1986) Therapeutic effects on cartilage metabolism in arthritis as measured by release of proteoglycan structures into the synovial fluid. Ann Rheum Dis 45: 491–497

    Article  PubMed  CAS  Google Scholar 

  63. Sharif M, Salisbury C, Taylor DJ, Kirwan JR (1998) Changes in biochemical markers of joint tissue metabolism in a randomized controlled trial of glucocorticoid in early rheumatoid arthritis. Arthritis Rheum 41: 1203–1209

    Article  PubMed  CAS  Google Scholar 

  64. Brennan FM, Browne KA, Green PA, Jaspar JM, Maini RN, Feldmann M (1997) Reduction of serum matrix metalloproteinase 1 and matrix metalloproteinase 3 in rheumatoid arthritis patients following anti-tumour necrosis factor-alpha (cA2) therapy. Br J Rheumatol 36: 643–650

    Article  PubMed  CAS  Google Scholar 

  65. Lindqvist E, Saxne T (1997) Cartilage macromolecules in knee joint synovial fluid. Markers of the disease course in patients with acute oligoarthritis. Ann Rheum Dis 56: 751–753

    Article  PubMed  CAS  Google Scholar 

  66. Lohmander LS, Dahlberg L, Eyre D, Lark M, Thonar EJ-MA, Ryd L (1998b) Longitudinal and cross-sectional variability in markers of joint metabolism in patients with knee pain and articular cartilage abnormalities. Osteoarthritis Cartilage 6: 351–361

    Article  PubMed  CAS  Google Scholar 

  67. Lohmander LS, Dahlberg L, Ryd L, Heinegård D (1989) Increased levels of proteoglycan fragments in knee joint fluid after injury. Arthritis Rheum 32: 1434–1442

    Article  PubMed  CAS  Google Scholar 

  68. Campion GV, Delmas PD, Dieppe PA (1989) Serum and synovial osteocalcin (bone Gla protein) levels in joint disease. Br J Rheumatol 28: 393–398

    Article  PubMed  CAS  Google Scholar 

  69. Mehraban F, Finegan CK, Moskowitz RW (1991) Serum keratan sulfate-quantitative and qualitative comparisons in inflammatory versus noninflammatory arthritides. Arthritis Rheum 34: 383–392

    Article  PubMed  CAS  Google Scholar 

  70. Hazell PK, Dent C, Fairclough JA, Bayliss MT, Hardingham TE (1995) Changes in glycosaminoglycan epitope levels in knee joint fluid following injury. Arthritis Rheum 38: 953–959

    Article  PubMed  CAS  Google Scholar 

  71. Slater Jr RR, Bayliss MT, Lachiewicz PF, Visco DM, Caterson B (1995) Monoclonal antibodies that detect biochemical markers of arthritis in humans. Arthritis Rheum 38: 655–659

    Article  PubMed  Google Scholar 

  72. Shinmei M, Miyauchi S, Machida A, Miyazaki K (1992) Quantitation of chondroitin 4-sulfate and chondroitin 6-sulfate in pathologic joint fluid. Arthritis Rheum 35: 1304–1308

    PubMed  CAS  Google Scholar 

  73. Witsch-Prehm P, Miehlke R, Kresse H (1992) Presence of small proteoglycan fragments in normal and arthritic human cartilage. Arthritis Rheum 35: 1042–1052

    Article  PubMed  CAS  Google Scholar 

  74. Saxne T, Heinegård D (1992b) Cartilage oligomeric matrix protein: a novel marker of cartilage turnover detectable in synovial fluid and blood. Br J Rheumatol 31: 583–591

    Article  PubMed  CAS  Google Scholar 

  75. Shinmei M, Ito K, Matsuyama S, Yoshihara Y, Matsuzawa K (1993) Joint fluid carboxyterminal type II procollagen peptide as a marker of cartilage collagen biosynthesis. Osteoarthritis Cartilage 1: 121–128

    Article  PubMed  CAS  Google Scholar 

  76. Hollander AP, Heathfield TF, Webber C, Iwata Y, Bourne R, Rorabeck C, Poole AR (1994) Increased damage to type II collagen in osteoarthritic cartilage detected by a new immunoassay. J Clin Invest 93: 1722–1732

    Article  PubMed  CAS  Google Scholar 

  77. Billinghurst RC, Dahlberg L, Ionescu M, Reiner A, Bourne R, Rorabeck C, Mitchell P, Hambor J, Diekmann O, Tschesche H, Chen J, Van Wart H, Poole AR (1997) Enhanced cleavage of type II collagen by collagenases in osteoarathritic articular cartilage. J Clin Invest 99: 1534–1545

    Article  PubMed  CAS  Google Scholar 

  78. Atley LM, Shao P, Shaffer K, Ochs V, Clemens JD, Eyre DR (1998) Collagen type II cross-linked telopeptides, a promising marker of cartilage degradation in arthritis (abstract). Transactions of Combined Orthopedic Research Societies Meeting, in press

    Google Scholar 

  79. Goldberg RL, Lenz ME, Huff J, Glickman P, Katz R. Thonar EJ-MA (1991) Elevated plasma levels of hyaluronate in patients with osteoarthritis and rheumatoid arthritis. Arthritis Rheum 34: 799–807

    Article  PubMed  CAS  Google Scholar 

  80. Hedin P-J, Weitoft T, Hedin H, Engström-Laurent A, Saxne T (1991) Serum concentrations of hyaluronan and proteoglycan in joint disease. Lack of association. J Rheumatol 18: 1601–1605

    PubMed  CAS  Google Scholar 

  81. Sharif M, George E, Dieppe PA (1996) Synovial fluid and serum concentrations of aminoterminal propeptide of type III procollagen in healthy volunteers and patients with joint disease. Ann Rheum Dis 55: 47–51

    Article  PubMed  CAS  Google Scholar 

  82. Lohmander LS, Saxne T, Heinegård D (1996b) Increased concentrations of bone sialoprotein in joint fluid after knee injury. Ann Rheum Dis 55: 622–626

    Article  PubMed  CAS  Google Scholar 

  83. Sharif M, George E, Dieppe PA (1995 c) Correlation between synovial fluid markers of cartilage and bone turnover and scintigraphic scan abnormalities in osteoarthritis of the knee. Arthritis Rheum 38: 78–81

    Article  PubMed  CAS  Google Scholar 

  84. Astbury C, Bird HA, McLaren AM, Robins SP (1994) Urinary excretion of pyridinium crosslinks of collagen correlated with joint damage in arthritis. Br J Rheumatol 33: 11–15

    Article  PubMed  CAS  Google Scholar 

  85. Thompson PW, Spector TD, James IT, Henderson E, Hart DJ (1992) Urinary collagen crosslinks reflect the radiographic severity of knee osteoarthritis. Br J Rheumatol 31: 759–761

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. L. S. Lohmander
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 1999 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Lohmander, L.S. (1999). The Role of Molecular Markers to Monitor Breakdown and Repair. In: Osteoarthritis. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-60026-5_15

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-60026-5_15

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-65127-7

  • Online ISBN: 978-3-642-60026-5

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation